Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this 24 week study is to compare the effectiveness and safety of different
doses of Niacin ER/Simvastatin (NS) in subjects with elevated fat levels in their blood
(dyslipidemia).
At least 600 subjects with a similar medical condition will take part in this study.